T helper type-2 cytokine responses: Potential therapeutic targets

Current Opinion in Pharmacology

Volumn 3, Issue 4, 2003, Pages 449-455

  Jarnicki, Andrew G ^a   Fallon, Padraic G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MYCOBACTERIUM VACCINE; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALLERGY; ASTHMA; ATOPY; CELLULAR IMMUNITY; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TARGETING; GENE SILENCING; GENE THERAPY; HELMINTHIASIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; TUBERCULOSIS;

ANIMALS; CYTOKINES; DRUG DELIVERY SYSTEMS; GENE SILENCING; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; RECEPTORS, CYTOKINE; TH1 CELLS; TH2 CELLS;

EID: 0042804869     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(03)00077-8     Document Type: Review

References (57)

1. Mosmann T.R. Cherwinski H. Bond M.W. Giedlin M.A. Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J. Immunol. 136 1986 2348-2357
2. Murphy K.M. Reiner S.L. The lineage decisions of helper T cells Nat. Rev. Immunol. 2 2002 933-944
3. Stetson D.B. Mohrs M. Mallet-Designe V. Teyton L. Locksley R.M. Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo Immunity 17 2002 191-200
4. Shinkai K. Mohrs M. Locksley R.M. Helper T cells regulate type-2 innate immunity in vivo Nature 420 2002 825-829
5. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers Nat. Rev. Immunol. 2 2002 389-400
6. Constant S.L. Brogdon J.L. Piggott D.A. Herrick C.A. Visintin I. Ruddle N.H. Bottomly K. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ J. Clin. Invest. 110 2002 1441-1448
7. de Jong E.C. Vieira P.L. Kalinski P. Schuitemaker J.H. Tanaka Y. Wierenga E.A. Yazdanbakhsh M. Kapsenberg M.L. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals J. Immunol. 168 2002 1704-1709
8. Dabbagh K. Dahl M.E. Stepick-Biek P. Lewis D.B. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells J. Immunol. 168 2002 4524-4530
9. Eisenbarth S.C. Piggott D.A. Huleatt J.W. Visintin I. Herrick C.A. Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen J. Exp. Med. 196 2002 1645-1651
10. Boonstra A. Asselin-Paturel C. Gilliet M. Crain C. Trinchieri G. Liu Y.J. O'Garra A. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation J. Exp. Med. 197 2003 101-109
11. Fort M.M. Cheung J. Yen D. Li J. Zurawski S.M. Lo S. Menon S. Clifford T. Hunte B. Lesley R. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo Immunity 15 2001 985-995
12. Hurst S.D. Muchamuel T. Gorman D.M. Gilbert J.M. Clifford T. Kwan S. Menon S. Seymour B. Jackson C. Kung T.T. et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25 J. Immunol. 169 2002 443-453
13. Wurster A.L. Rodgers V.L. Satoskar A.R. Whitters M.J. Young D.A. Collins M. Grusby M.J. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells J. Exp. Med. 196 2002 969-977
14. Umetsu D.T. McIntire J.J. Akbari O. Macaubas C. DeKruyff R.H. Asthma: an epidemic of dysregulated immunity Nat. Immunol. 3 2002 715-720
15. Sheikh A. Smeeth L. Hubbard R. There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis J. Allergy Clin. Immunol. 111 2003 131-135
16. Marsh D.G. Neely J.D. Breazeale D.R. Ghosh B. Freidhoff L.R. Ehrlich-Kautzky E. Schou C. Krishnaswamy G. Beaty T.H. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations Science 264 1994 1152-1156
17. Morahan G. Huang D. Wu M. Holt B.J. White G.P. Kendall G.E. Sly P.D. Holt P.G. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children Lancet 360 2002 455-459
18. Raby B.A. Klimecki W.T. Laprise C. Renaud Y. Faith J. Lemire M. Greenwood C. Weiland K.M. Lange C. Palmer L.J. et al. Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes Am. J. Respir. Crit. Care Med. 166 2002 1449-1456
19. Lazarus R. Klimecki W.T. Raby B.A. Vercelli D. Palmer L.J. Kwiatkowski D.J. Silverman E.K. Martinez F. Weiss S.T. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three US ethnic groups and exploratory case-control disease association studies Genomics 81 2003 85-91
20. Foster P.S. Hogan S.P. Ramsay A.J. Matthaei K.I. Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model J. Exp. Med. 183 1996 195-201
21. Hamelmann E. Oshiba A. Loader J. Larsen G.L. Gleich G. Lee J. Gelfand E.W. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization Am. J. Respir. Crit. Care Med. 155 1997 819-825
22. Shen H.H. Ochkur S.I. McGarry M.P. Crosby J.R. Hines E.M. Borchers M.T. Wang H. Biechelle T.L. O'Neill K.R. Ansay T.L. et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse J. Immunol. 170 2003 3296-3305
23. Leckie M.J. ten Brinke A. Khan J. Diamant Z. O'Connor B.J. Walls C.M. Mathur A.K. Cowley H.C. Chung K.F. Djukanovic R. et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144-2148
24. Flood-Page P.T. Menzies-Gow A.N. Kay A.B. Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway Am. J. Respir. Crit. Care Med. 167 2003 199-204
25. Busse W.W. Kelly E.A. Is the eosinophil a 'Humpty Dumpty' cell in asthma? Am. J. Respir. Crit. Care Med. 167 2003 102-103
26. Rizzo C.A. Yang R. Greenfeder S. Egan R.W. Pauwels R.A. Hey J.A. The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness J. Allergy Clin. Immunol. 109 2002 404-409
27. Menzies-Gow A. Ying S. Sabroe I. Stubbs V.L. Soler D. Williams T.J. Kay A.B. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers J. Immunol. 169 2002 2712-2718
28. Ma W. Bryce P.J. Humbles A.A. Laouini D. Yalcindag A. Alenius H. Friend D.S. Oettgen H.C. Gerard C. Geha R.S. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation J. Clin. Invest. 109 2002 621-628
29. Humbles A.A. Lu B. Friend D.S. Okinaga S. Lora J. Al-Garawi A. Martin T.R. Gerard N.P. Gerard C. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness Proc. Natl. Acad. Sci. USA 99 2002 1479-1484
30. Fallon P.G. Jolin H.E. Smith P. Emson C.L. Townsend M.J. Fallon R. McKenzie A.N. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9 and IL-13 Immunity 17 2002 7-17
31. Proust B. Nahori M.A. Ruffie C. Lefort J. Vargaftig B.B. Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic BALB/c and IL-4Ralpha knockout mice Clin. Exp. Allergy 33 2003 119-131
32. Borish L.C. Nelson H.S. Corren J. Bensch G. Busse W.W. Whitmore J.B. Agosti J.M. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma J. Allergy Clin. Immunol. 107 2001 963-970
33. McKenzie A.N.J. Fallon P.G. Decoy receptors in the regulation of T helper cell type 2 responses J. Exp. Med. 197 2003 675-679
34. Donaldson D.D. Whitters M.J. Fitz L.J. Neben T.Y. Finnerty H. Henderson S.L. O'Hara R.M. Jr. Beier D.R. Turner K.J. Wood C.R. et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1 J. Immunol. 161 1998 2317-2324
35. Chiaramonte M.G. Mentink-Kane M. Jacobson B.A. Cheever A.W. Whitters M.J. Goad M.E.P. Wong A. Collins M. Donaldson D.D. Grusby M.J. et al. Regulation and function of the interleukin 13 receptor 2 during a T helper cell type 2-dominant immune response J. Exp. Med. 197 2003 687-701
36. Wood N. Whitters M.J. Jacobson B.A. Witek J. Sypek J.P. Kasaian M. Eppihimer M.J. Unger M. Tanaka T. Goldman S.J. et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α2 J. Exp. Med. 197 2003 703-709
37. Chiaramonte M.G. Donaldson D.D. Cheever A.W. Wynn T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response J. Clin. Invest. 104 1999 777-785
38. Fallon P.G. Richardson E.J. McKenzie G.J. McKenzie A.N. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent J. Immunol. 164 2000 2585-2591
39. Economides A.N. Carpenter L.R. Rudge J.S. Wong V. Koehler-Stec E.M. Hartnett C. Pyles E.A. Xu X. Daly T.J. Young M.R. et al. Cytokine traps: multi-component, high-affinity blockers of cytokine action Nat. Med. 9 2003 47-52
40. Kaplan M.H. Schindler U. Smiley S.T. Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells Immunity 4 1996 313-319
41. Kuperman D.A. Huang X. Koth L.L. Chang G.H. Dolganov G.M. Zhu Z. Elias J.A. Sheppard D. Erle D.J. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma Nat. Med. 8 2002 885-889
42. Egwuagu C.E. Yu C.R. Zhang M. Mahdi R.M. Kim S.J. Gery I. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance J. Immunol. 168 2002 3181-3187
43. Seki Y. Hayashi K. Matsumoto A. Seki N. Tsukada J. Ransom J. Naka T. Kishimoto T. Yoshimura A. Kubo M. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation Proc. Natl. Acad. Sci. USA 99 2002 13003-13008
44. Rengarajan J. Tang B. Glimcher L.H. NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naive T(H)cells Nat. Immunol. 3 2002 48-54
45. Rengarajan J. Mowen K.A. McBride K.D. Smith E.D. Singh H. Glimcher L.H. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression J. Exp. Med. 195 2002 1003-1012
46. Mohrs M. Blankespoor C.M. Wang Z.E. Loots G.G. Afzal V. Hadeiba H. Shinkai K. Rubin E.M. Locksley R.M. Deletion of a coordinate regulator of type 2 cytokine expression in mice Nat. Immunol. 2 2001 842-847
47. Solymar D.C. Agarwal S. Bassing C.H. Alt F.W. Rao A.A 3′ enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells Immunity 17 2002 41-50
48. Santangelo S. Cousins D.J. Winkelmann N.E. Staynov D.Z. DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4(+) T cell differentiation J. Immunol. 169 2002 1893-1903
49. Hutchins A.S. Mullen A.C. Lee H.W. Sykes K.J. High F.A. Hendrich B.D. Bird A.P. Reiner S.L. Gene silencing quantitatively controls the function of a developmental trans-activator Mol. Cell. 10 2002 81-91
50. Karulin A.Y. Hesse M.D. Yip H.C. Lehmann P.V. Indirect IL-4 pathway in type 1 immunity J. Immunol. 168 2002 545-553
51. Zuany-Amorim C. Sawicka E. Manlius C. Le Moine A. Brunet L.R. Kemeny D.M. Bowen G. Rook G. Walker C. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells Nat. Med. 8 2002 625-629
52. Hopfenspirger M.T. Agrawal D.K. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice J. Immunol. 168 2002 2516-2522
53. Ozdemir C. Akkoc T. Bahceciler N.N. Kucukercan D. Barlan I.B. Basaran M.M. Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma Clin. Exp. Allergy 33 2003 266-270
54. van der Kleij D. Latz E. Brouwers J.F. Kruize Y.C. Schmitz M. Kurt-Jones E.A. Espevik T. de Jong E.C. Kapsenberg M.L. Golenbock D.T. et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization J. Biol. Chem. 277 2002 48122-48129
55. Finotto S. De Sanctis G.T. Lehr H.A. Herz U. Buerke M. Schipp M. Bartsch B. Atreya R. Schmitt E. Galle P.R. et al. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression J. Exp. Med. 193 2001 1247-1260
56. Song E. Lee S.K. Wang J. Ince N. Ouyang N. Min J. Chen J. Shankar P. Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis Nat. Med. 9 2003 347-351
57. Gardam M.A. Keystone E.C. Menzies R. Manners S. Skamene E. Long R. Vinh D.C. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management Lancet Infect. Dis. 3 2003 148-155